Vigeo Therapeutics Company
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2011
Employees Number:
11-50
Total Funding:
10000000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Debt Financing
Register and Claim Ownership